School is back in session! THC % matters—but it’s not the whole story. Cannabis …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. THCCBDResearchDosingSafetyIndustryMental Health Why This Matters Clinicians should counsel patients that THC potency…
CBD shows potential to broadly affect leukaemia cells by boosting immune responses …
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDCancerResearchSafetyNeurologyMental HealthPolicy Why This Matters This research suggesting CBD may enhance immune…
Athletes on Medical Cannabis Want Sleep and Focus, Not Muscle Recovery, Study Finds
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepResearchSafetyMental HealthAnxietyDosingPolicy Why This Matters Clinicians should understand that athletes using…
New Parliamentary Friendship Group champions safer medicines use
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyMental HealthAgingNeurologyDosing Why This Matters Clinicians need to understand that cannabis…
UK Medical Cannabis Prescriptions Hit 1.7 Million in 2025 as ACMD Review Approaches
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryPainAnxietyMental Health Why This Matters As medical cannabis prescriptions in the UK reach…
Refractory Status Epilepticus, Serotonin Syndrome, and Fulminant Multiorgan Failure … – Scirp.org.
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologySafetyResearchMental HealthTHCCBDAnxiety Why This Matters Clinicians need to recognize that synthetic…
Cannabis Use and the Age-Related Acceleration of Psychosis Onset: What a New 149-Study Meta-Analysis Shows
This meta-analysis of 149 studies examines cannabis use age at onset psychosis, finding users experience psychosis onset 2.50 years earlier than nonusers on average. The age gap widens with increasing age, reaching 6.30 years earlier at 30 and older.…
Cannabis isn’t ‘safer’ in your 20s and 30s – it’s linked to an earlier onset of psychosis
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. Mental HealthTHCSafetyResearchNeurologyDosingAging Why This Matters Clinicians need to recognize that cannabis use during…
Brain’s cannabinoid system links persistent anxiety to stronger alcohol reward learning
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AnxietyMental HealthNeurologyResearchSafetyPolicyPain Why This Matters Clinicians treating patients with comorbid anxiety…
Op-Ed | New York needs to get THC beverages right | amNewYork
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. THCSafetyPolicyDosingIndustryMental HealthAnxiety Why This Matters Clinicians need to understand THC beverage risks…